net dbt
hold line ep difficult
multitud headwind
expect guidanc pressur upcom call
follow manag commentari recent confer given on-going
industri headwind lower estim walgreen ahead
result lower price object ep lower
estim vs previou number headwind plagu industri
whole lower brand price time gener calendar includ like
moder increment gener sourc save reimburs headwind
issu face within pharmaci busi compani recent
script growth closer in-lin market trail growth given
higher degre prefer network activ within book busi
expect trend shift dramat near-term basi benefit
non-organ script growth includ store addit rx file buy
also done commend job manag oper expens
expect overcom view signific gross profit headwind
factor continu weigh us retail busi intern busi
deal government-bas price pressur well goe
partnership model drive improv core oper profit perform
see visibl pathway meaning acceler thu reiter
ep reduct primarili driven gm pressur
lower ep ep
new ep estim low end manag guidanc
biggest differ reduc estim lower expect gross margin
within us retail busi estim low-singl digit same-stor rx
growth unchang would also note manag continu execut
long-term cost reduct plan would surpris see
cost reduct reinvest busi particularli area wba recently-
announc partnership opportun creat better digit connect
store appeal one take time invest prior
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
walgreen follow complet rite
aid store acquisit largest global
pharmaci nearli store us
alon compani also oper intern
pharmaci busi primarili compos
boot pharmaci unit kingdom
allianc healthcar intern wholesal
distributor pharmaceut medic
product europ walgreen headquart
under-perform rate predic
market headwind competit dynam
exacerb concern around pend
amazon entri market core profit
dollar growth slow think limit visibl
creat challeng near-term stock
perform view range-bound
recent earn histori told us
despit profit volatil ep remain safe
one common refrain someth ceo stefano pessina
focus commit grow ep achiev ep target
earn reput recent outperform consensu ep everi singl quarter
sinc period averag ep out-performance
exhibit demonstr steadi consist ep out-performance vs consensu estim
compani report bloomberg
even steadi ep perform alway oper driven
recent last four quarter volatil come gross
profit oper profit side particularli within us retail pharmaci busi
gross profit volatil caus on-going reimburs pressur well
mix shift aid growth new store well allianc one
prime therapeut specialti meanwhil manag remain focus
control oper expens well lead steadier ebit perform
part
exhibit gross profit impact reimburs chang
exhibit ebit aid focu opex manag
compani file bofa merril lynch global research
compani file bofa merril lynch global research
sg trend particular one remain intens focu investor
sg revenu come consist total sg dollar grow
slower rate revenu
exhibit sg revenu come consist
sg revenu
sg revenu
compani file bofa merril lynch global research
exhibit total sg grown slower pace total revenu
compani file bofa merril lynch global research
manag target long-term cost reduct plan like
pace sg perform continu howev given new store initi well
digit invest take place part new partnership
interest track much gross save target end flow
price object base ep
multipl five-year averag absolut basi around discount
five-year averag reflect view walgreen core retail pharmaci busi
long-term structur pressur must diversifi stabl busi line
improv growth outlook
upsid risk better expect gener save new partnership
healthcar area labcorp etc support long-
term growth addit volum econdisc/rit aid contribut
addit new partnership faster expect growth prime therapeut
relationship downsid risk po on-going price reimburs pressur
higher prescript attrit part relationship integr risk rite
aid risk amazon anoth disrupt forc enter suppli chain market
lack avail attract capit deploy opportun
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
